Change in total lesion PSMA (TLP) during [177Lu]Lu-PSMA-617 radioligand therapy predicts overall survival in patients with mCRPC: monocentric evaluation of a prospective registry.
Eur J Nucl Med Mol Imaging
; 51(3): 885-895, 2024 Feb.
Article
in En
| MEDLINE
| ID: mdl-37889298
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostate-Specific Antigen
/
Prostatic Neoplasms, Castration-Resistant
/
Gallium Radioisotopes
Limits:
Humans
/
Male
Language:
En
Journal:
Eur J Nucl Med Mol Imaging
Journal subject:
MEDICINA NUCLEAR
Year:
2024
Document type:
Article
Affiliation country:
Germany
Country of publication:
Germany